These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31648878)

  • 1. The plant-derived chalcone Xanthoangelol targets the membrane of Gram-positive bacteria.
    Meier D; Hernández MV; van Geelen L; Muharini R; Proksch P; Bandow JE; Kalscheuer R
    Bioorg Med Chem; 2019 Dec; 27(23):115151. PubMed ID: 31648878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal Biosynthesis Inhibition with Ambuic Acid as a Strategy To Target Antibiotic-Resistant Infections.
    Todd DA; Parlet CP; Crosby HA; Malone CL; Heilmann KP; Horswill AR; Cech NB
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity of two chalcones, xanthoangelol and 4-hydroxyderricin, isolated from the root of Angelica keiskei KOIDZUMI.
    Inamori Y; Baba K; Tsujibo H; Taniguchi M; Nakata K; Kozawa M
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1604-5. PubMed ID: 1934181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhodomyrtosone B, a membrane-targeting anti-MRSA natural acylgphloroglucinol from Rhodomyrtus tomentosa.
    Zhao LY; Liu HX; Wang L; Xu ZF; Tan HB; Qiu SX
    J Ethnopharmacol; 2019 Jan; 228():50-57. PubMed ID: 30195566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antibacterial evaluation of novel cationic chalcone derivatives possessing broad spectrum antibacterial activity.
    Chu WC; Bai PY; Yang ZQ; Cui DY; Hua YG; Yang Y; Yang QQ; Zhang E; Qin S
    Eur J Med Chem; 2018 Jan; 143():905-921. PubMed ID: 29227931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new reduced chalcone-derivative affects the membrane permeability and electric potential of multidrug-resistant Enterococcusfaecalis.
    Tempone AG; Theodoro RDS; Romanelli MM; Santos Ferreira DA; Amaral M; Ribeiro de Assis L; Santa Cruz LM; Costa AR; Zanella RC; Christodoulides M; Regasini LO; Camargo CH
    Chem Biol Interact; 2022 Sep; 365():110086. PubMed ID: 35940279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neofiscalin A and fiscalin C are potential novel indole alkaloid alternatives for the treatment of multidrug-resistant Gram-positive bacterial infections.
    Bessa LJ; Buttachon S; Dethoup T; Martins R; Vasconcelos V; Kijjoa A; Martins da Costa P
    FEMS Microbiol Lett; 2016 Aug; 363(15):. PubMed ID: 27268269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferrocenyl chalcone derivatives as possible antimicrobial agents.
    Henry EJ; Bird SJ; Gowland P; Collins M; Cassella JP
    J Antibiot (Tokyo); 2020 May; 73(5):299-308. PubMed ID: 31988484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telavancin: mechanisms of action, in vitro activity, and mechanisms of resistance.
    Karlowsky JA; Nichol K; Zhanel GG
    Clin Infect Dis; 2015 Sep; 61 Suppl 2():S58-68. PubMed ID: 26316559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tolerance and heteroresistance in Gram-positive microorganisms].
    Morosini MI; Cantón R
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():16-22. PubMed ID: 21477700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro and in Vivo Evaluation of Membrane-Active Flavone Amphiphiles: Semisynthetic Kaempferol-Derived Antimicrobials against Drug-Resistant Gram-Positive Bacteria.
    Lin S; Li H; Tao Y; Liu J; Yuan W; Chen Y; Liu Y; Liu S
    J Med Chem; 2020 Jun; 63(11):5797-5815. PubMed ID: 32400157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of the infection by resistant Gram-positive microorganisms].
    Cercenado E
    Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():6-9. PubMed ID: 27608305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oritavancin: a long-acting antibacterial lipoglycopeptide.
    Kaasch AJ; Seifert H
    Future Microbiol; 2016 Jul; 11():843-55. PubMed ID: 27161039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symmetrically Substituted Xanthone Amphiphiles Combat Gram-Positive Bacterial Resistance with Enhanced Membrane Selectivity.
    Lin S; Koh JJ; Aung TT; Lim F; Li J; Zou H; Wang L; Lakshminarayanan R; Verma C; Wang Y; Tan DT; Cao D; Beuerman RW; Ren L; Liu S
    J Med Chem; 2017 Feb; 60(4):1362-1378. PubMed ID: 28122182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurone derivatives as promising antibacterial agents against resistant Gram-positive pathogens.
    Olleik H; Yahiaoui S; Roulier B; Courvoisier-Dezord E; Perrier J; Pérès B; Hijazi A; Baydoun E; Raymond J; Boumendjel A; Maresca M; Haudecoeur R
    Eur J Med Chem; 2019 Mar; 165():133-141. PubMed ID: 30665143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of resistant Gram-positive bacterial infections].
    Lenoble M
    Med Mal Infect; 2011 Sep; 41(9 Suppl):1-6. PubMed ID: 22133738
    [No Abstract]   [Full Text] [Related]  

  • 18. Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.
    Lamb HM; Figgitt DP; Faulds D
    Drugs; 1999 Dec; 58(6):1061-97. PubMed ID: 10651391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold Nanoclusters for Targeting Methicillin-Resistant Staphylococcus aureus In Vivo.
    Xie Y; Liu Y; Yang J; Liu Y; Hu F; Zhu K; Jiang X
    Angew Chem Int Ed Engl; 2018 Apr; 57(15):3958-3962. PubMed ID: 29423995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenolic chalcones lead to ion leakage from Gram-positive bacteria prior to cell death.
    Ergüden B; Ünver Y
    Arch Microbiol; 2021 Nov; 204(1):3. PubMed ID: 34870746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.